Seamless Cardiology EPCS Integration for Efficient Prescribing

Achieving seamless cardiology EPCS integration is critical for cardiovascular practices managing high-volume specialty drug prescriptions and post-procedure care. Klivira automates the electronic prescribing of controlled substances, ensuring compliance and operational efficiency.

Cardiology practices frequently prescribe controlled substances, including specific anticoagulants or pain management medications post-procedure, making efficient and compliant electronic prescribing a necessity. Navigating the stringent requirements of DEA EPCS while maintaining patient care flow presents a significant administrative challenge. Our platform streamlines this process, integrating directly with your EMR to minimize manual steps and reduce the risk of errors.

Understanding EPCS in Cardiology Workflows

Electronic Prescribing of Controlled Substances (EPCS) is a critical component of modern cardiology practice, particularly when managing specific post-procedural pain medications or certain anticoagulants that fall under controlled substance regulations. Efficient cardiology EPCS integration ensures that cardiovascular providers can securely and compliantly prescribe these medications, minimizing delays for patients and reducing administrative burden.

Key Considerations for Cardiology EPCS Integration

  • Adherence to DEA EPCS standards for controlled substance prescribing.
  • Integration with identity proofing and authentication solutions like Imprivata or Identity Automation.
  • Secure handling of ePHI in compliance with HIPAA throughout the prescribing workflow.
  • Seamless connectivity with EMR systems to pull patient data and push prescription orders.
  • Minimizing disruption to existing clinical workflows for high-volume cardiology procedures and drug regimens.

How Klivira Supports Cardiology EPCS

Klivira's platform provides robust support for cardiology EPCS integration, streamlining the complex process of electronically prescribing controlled substances. Our solution integrates directly with your existing EMR, enabling cardiovascular providers to generate and transmit EPCS-compliant prescriptions efficiently, reducing manual data entry and potential errors.

EMR and Payer Touchpoints in Cardiology EPCS

Effective cardiology EPCS integration requires seamless interaction across various EMR modules, including medication order entry, patient demographics, and clinical documentation. While EPCS primarily involves direct pharmacy communication, the underlying patient data and prior authorization for related non-controlled specialty drugs in cardiology (e.g., PCSK9 inhibitors or sacubitril/valsartan) often involve payer portals or specialty benefit managers for comprehensive care coordination.

Ensuring Compliance and Security in EPCS Workflows

Compliance with DEA EPCS regulations and HIPAA for ePHI security is paramount for any cardiology EPCS integration. Klivira designs its workflows to meet these stringent requirements, ensuring that all electronic prescriptions for controlled substances are transmitted securely and that audit trails are meticulously maintained, providing peace of mind for your compliance team.

Frequently asked questions

What is DEA EPCS and why is it important for cardiology practices?

DEA EPCS (Electronic Prescribing of Controlled Substances) allows providers to electronically transmit prescriptions for controlled substances, replacing paper-based methods. For cardiology, this is crucial for securely prescribing certain anticoagulants or post-procedural pain medications, enhancing patient safety, reducing fraud, and improving workflow efficiency.

How does Klivira integrate with our existing EMR for cardiology EPCS?

Klivira integrates directly with your EMR system, leveraging standards like SMART on FHIR where applicable, to facilitate the secure and compliant electronic prescribing of controlled substances. This integration ensures that patient data is accurately pulled for prescription generation and that the completed prescriptions are seamlessly transmitted to pharmacies.

Which identity providers does Klivira support for EPCS authentication?

Klivira supports integration with leading identity proofing and authentication solutions required for EPCS, including Imprivata and Identity Automation. This ensures that only authorized personnel can electronically sign and transmit controlled substance prescriptions, adhering to DEA requirements.

Does EPCS integration also help with prior authorizations for cardiology drugs?

While EPCS specifically addresses the electronic prescribing of controlled substances directly to pharmacies, Klivira's broader platform also automates prior authorizations for a wide range of cardiology specialty drugs, such as PCSK9 inhibitors or sacubitril/valsartan. This comprehensive approach streamlines both prescribing and authorization workflows.

Related coverage

Other cardiology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo